Non-Current Assets
Deferred Tax Assets
West Pharmaceutical Services Deferred Tax Assets increased by 66.4% to $63.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 145.8%, from $26.00M to $63.90M. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets shows an upward trend with a 19.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ4 2019
Last reportedQ1 2026
How to read this metric
An increase may indicate past operating losses or tax credits that provide a future buffer, while a decrease suggests the utilization of these benefits to offset tax liabilities.
Detailed definition
This represents the future tax benefits that the company expects to realize due to temporary differences between the fin...
Peer comparison
Standard across all industries; levels depend heavily on the company's historical profitability and tax jurisdiction profile.
Metric ID:
non_current_assets_deferred_income_tax_assets_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.80M | $80.00M | $48.50M | $66.40M | $49.40M | $63.00M | $65.60M | $99.00M | $67.00M | $17.30M | $25.70M | $21.00M | $33.90M | $37.60M | $26.00M | $26.00M | $29.70M | $27.90M | $38.40M | $63.90M |
| QoQ Change | — | +177.8% | -39.4% | +36.9% | -25.6% | +27.5% | +4.1% | +50.9% | -32.3% | -74.2% | +48.6% | -18.3% | +61.4% | +10.9% | -30.9% | +0.0% | +14.2% | -6.1% | +37.6% | +66.4% |
| YoY Change | — | — | — | — | +71.5% | -21.3% | +35.3% | +49.1% | +35.6% | -72.5% | -60.8% | -78.8% | -49.4% | +117.3% | +1.2% | +23.8% | -12.4% | -25.8% | +47.7% | +145.8% |
Range$17.30M – $99.00M
CAGR+18.3%
Avg YoY Growth+12.9%
Median YoY Growth+12.5%
Current Streak2 quarters growth
Deferred Tax Assets at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's deferred tax assets?
- West Pharmaceutical Services (WST) reported deferred tax assets of $63.90M in Q1 2026.
- How has West Pharmaceutical Services's deferred tax assets changed year-over-year?
- West Pharmaceutical Services's deferred tax assets increased by 145.8% year-over-year, from $26.00M to $63.90M.
- What is the long-term trend for West Pharmaceutical Services's deferred tax assets?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's deferred tax assets has grown at a 19.1% compound annual growth rate (CAGR), from $16.00M to $38.40M.
- What does deferred tax assets mean?
- Future tax savings the company expects to realize based on past financial activities.